Join
Live feed
·
INSIDERFilingvia Quantisnow
ACADIA Pharmaceuticals Inc. logo

EVP, COO, HEAD OF COMMERCIAL Teehan Brendan converted options into 19,826 shares and sold $173,630 worth of shares (10,329 units at $16.81), increasing direct ownership by 18% to 62,105 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACAD (ACADIA Pharmaceuticals Inc.) and more on Quantisnow.